Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy

ClinicalTrials.gov ID: NCT01676116

Public ClinicalTrials.gov record NCT01676116. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 9:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy (DUAL™ III -GLP-1 Switch)

Study identification

NCT ID
NCT01676116
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
438 participants

Conditions and interventions

Interventions

  • exenatide Drug
  • insulin degludec/liraglutide Drug
  • liraglutide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 28, 2012
Primary completion
Mar 10, 2014
Completion
Mar 10, 2014
Last update posted
Jan 2, 2019

2012 – 2014

United States locations

U.S. sites
85
U.S. states
26
U.S. cities
76
Facility City State ZIP Site status
Novo Nordisk Investigational Site Birmingham Alabama 35216
Novo Nordisk Investigational Site Goodyear Arizona 85395
Novo Nordisk Investigational Site Mesa Arizona 85206
Novo Nordisk Investigational Site Phoenix Arizona 85018
Novo Nordisk Investigational Site Concord California 94520
Novo Nordisk Investigational Site Encino California 91436
Novo Nordisk Investigational Site Fair Oaks California 95628
Novo Nordisk Investigational Site Fresno California 93720
Novo Nordisk Investigational Site Greenbrae California 94904
Novo Nordisk Investigational Site Lancaster California 93534
Novo Nordisk Investigational Site Lomita California 90717
Novo Nordisk Investigational Site Long Beach California 90806
Novo Nordisk Investigational Site Montclair California 91763
Novo Nordisk Investigational Site Northridge California 91325
Novo Nordisk Investigational Site San Mateo California 94401
Novo Nordisk Investigational Site San Ramon California 94583
Novo Nordisk Investigational Site Tarzana California 91356-3551
Novo Nordisk Investigational Site Van Nuys California 91405
Novo Nordisk Investigational Site Colorado Springs Colorado 80910
Novo Nordisk Investigational Site Bradenton Florida 34201
Novo Nordisk Investigational Site Fort Myers Florida 33912-4343
Novo Nordisk Investigational Site Jacksonville Florida 32204
Novo Nordisk Investigational Site Jacksonville Florida 32207
Novo Nordisk Investigational Site Jacksonville Florida 32216
Novo Nordisk Investigational Site Jacksonville Florida 32258
Novo Nordisk Investigational Site Miami Florida 33135
Novo Nordisk Investigational Site Miami Florida 33136
Novo Nordisk Investigational Site Miami Florida 33155
Novo Nordisk Investigational Site Miami Florida 33156
Novo Nordisk Investigational Site Miami Springs Florida 33166
Novo Nordisk Investigational Site Orlando Florida 32806
Novo Nordisk Investigational Site Plant City Florida 33563
Novo Nordisk Investigational Site Winter Haven Florida 33880
Novo Nordisk Investigational Site Atlanta Georgia 30318
Novo Nordisk Investigational Site Roswell Georgia 30076
Novo Nordisk Investigational Site Honolulu Hawaii 96814
Novo Nordisk Investigational Site Arlington Heights Illinois 60004-2315
Novo Nordisk Investigational Site Indianapolis Indiana 46254
Novo Nordisk Investigational Site Lexington Kentucky 40503
Novo Nordisk Investigational Site Rockville Maryland 20852
Novo Nordisk Investigational Site Kalamazoo Michigan 49048
Novo Nordisk Investigational Site Troy Michigan 48098
Novo Nordisk Investigational Site Saint Charles Missouri 63303
Novo Nordisk Investigational Site Omaha Nebraska 68124
Novo Nordisk Investigational Site Henderson Nevada 89052-2649
Novo Nordisk Investigational Site Las Vegas Nevada 89128
Novo Nordisk Investigational Site Reno Nevada 89502-0111
Novo Nordisk Investigational Site Nashua New Hampshire 03063
Novo Nordisk Investigational Site Berlin New Jersey 08009
Novo Nordisk Investigational Site Flemington New Jersey 08822-5763
Novo Nordisk Investigational Site Hamilton New Jersey 08619
Novo Nordisk Investigational Site Lawrenceville New Jersey 08648
Novo Nordisk Investigational Site Toms River New Jersey 08753-2975
Novo Nordisk Investigational Site Mineola New York 11501
Novo Nordisk Investigational Site North Massapequa New York 11758-1802
Novo Nordisk Investigational Site West Seneca New York 14224
Novo Nordisk Investigational Site Morehead City North Carolina 28557
Novo Nordisk Investigational Site Columbus Ohio 43214
Novo Nordisk Investigational Site Dayton Ohio 45439
Novo Nordisk Investigational Site Altoona Pennsylvania 16602
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15243
Novo Nordisk Investigational Site Myrtle Beach South Carolina 29572
Novo Nordisk Investigational Site Sumter South Carolina 29150-1900
Novo Nordisk Investigational Site Chattanooga Tennessee 37404
Novo Nordisk Investigational Site Jellico Tennessee 37762
Novo Nordisk Investigational Site Kingsport Tennessee 37660
Novo Nordisk Investigational Site Nashville Tennessee 37212
Novo Nordisk Investigational Site Tullahoma Tennessee 37388
Novo Nordisk Investigational Site Arlington Texas 76014
Novo Nordisk Investigational Site Austin Texas 78731
Novo Nordisk Investigational Site Dallas Texas 75218
Novo Nordisk Investigational Site Dallas Texas 75231
Novo Nordisk Investigational Site Fort Worth Texas 76113
Novo Nordisk Investigational Site Houston Texas 77074
Novo Nordisk Investigational Site Houston Texas 77095
Novo Nordisk Investigational Site Plano Texas 75075
Novo Nordisk Investigational Site Round Rock Texas 78681
Novo Nordisk Investigational Site San Antonio Texas 78215
Novo Nordisk Investigational Site San Antonio Texas 78249
Novo Nordisk Investigational Site Schertz Texas 78154
Novo Nordisk Investigational Site Sugar Land Texas 77478
Novo Nordisk Investigational Site Orem Utah 84058
Novo Nordisk Investigational Site Salt Lake City Utah 84107
Novo Nordisk Investigational Site St. George Utah 84790
Novo Nordisk Investigational Site Richmond Virginia 23219

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01676116, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 2, 2019 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01676116 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →